Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-20

FDA Approved: FAMOTIDINE — Original Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Westminster Pharmaceuticals' original ANDA for famotidine, a generic H2 blocker used to treat ulcers and GERD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)